Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Sezary Syndrome 4Mycosis Fungoides 3Lymphoma, T-Cell, Cutaneous 3Neoplasms 2Graft vs Host Disease 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid 1Leukemia, Lymphoid 1Leukemia 1Immunologic Deficiency Syndromes 1Hodgkin Disease 1Hemoglobinopathies 1Hematologic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 254fludarabine phosphate 165Cytarabine 160Methotrexate 128Busulfan 115Filgrastim 111fludarabine 102Peripheral Blood Stem Cell Transplantation 96Rituximab 94Antilymphocyte Serum 83Etoposide 81Cyclosporine 75Tacrolimus 74Mycophenolic Acid 73Whole-Body Irradiation 72Radiotherapy 70Melphalan 66Vincristine 55Dexamethasone 54Granulocyte Colony-Stimulating Factor 50Methylprednisolone 48Azacitidine 44Alemtuzumab 42Imatinib Mesylate 41Clofarabine 41sargramostim 40Idarubicin 36Daunorubicin 36Cord Blood Stem Cell Transplantation 36Mercaptopurine 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Leukemia × Photopheresis × Clear all
NCT00179790 2017-03-06

Reduced Intensity Transplant Using Extracorporeal Photopheresis

Ann & Robert H Lurie Children's Hospital of Chicago

Phase 1/2 Completed
22 enrolled
Other hematologic neoplasm

Hemoglobinopathies, Immunologic Deficiency Syndromes, Leukemia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡